التالي
The deadline for the job posting is the 2nd November 2026.Job purpose:As a major global biopharma company and one of the UKs largest listed businesses GSK generates considerable media interest.Journalists reporting on business science health and political affairs all cover GSK on a da
The deadline for the job posting is the 2nd November 2026.Job purpose:As a major global biopharma company and one of the UKs largest listed businesses GSK generates considerable media interest.Journalists reporting on business science health and political affairs all cover GSK on a da
At GSK we unite science technology and talent to get ahead of disease together. We are a global biopharma company with a special purpose to unite science technology and talent to get ahead of disease together. Were proud to be leading a healthcare revolution and were looking for peop
At GSK we unite science technology and talent to get ahead of disease together. We are a global biopharma company with a special purpose to unite science technology and talent to get ahead of disease together. Were proud to be leading a healthcare revolution and were looking for peop
Analytical Network Strategy Senior DirectorAt GSK we have bold ambitions for patients aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines combining our understanding of the immune s
Analytical Network Strategy Senior DirectorAt GSK we have bold ambitions for patients aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines combining our understanding of the immune s
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Director ServiceNow Data Intelligence & Experience Product ManagerWhy Us!At GSK we unite science technology and talent to get ahead of disease together. We are a global biopharma company with a special purpose to unite science technology and talent to get ahead of disease together. W
Director ServiceNow Data Intelligence & Experience Product ManagerWhy Us!At GSK we unite science technology and talent to get ahead of disease together. We are a global biopharma company with a special purpose to unite science technology and talent to get ahead of disease together. W
ServiceNow Technical & Enablement ArchitectWhy Us!At GSK we unite science technology and talent to get ahead of disease together. We are a global biopharma company with a special purpose to unite science technology and talent to get ahead of disease together. Were proud to be leading
ServiceNow Technical & Enablement ArchitectWhy Us!At GSK we unite science technology and talent to get ahead of disease together. We are a global biopharma company with a special purpose to unite science technology and talent to get ahead of disease together. Were proud to be leading
Director Product Owner - Payroll & Time Digital & TechWhy Us!At GSK we unite science technology and talent to get ahead of disease together. We are a global biopharma company with a special purpose to unite science technology and talent to get ahead of disease together. Were proud to
Director Product Owner - Payroll & Time Digital & TechWhy Us!At GSK we unite science technology and talent to get ahead of disease together. We are a global biopharma company with a special purpose to unite science technology and talent to get ahead of disease together. Were proud to
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Territory: Covers Dallas Mesquite Tyler and Longview TXIdeal candidate should reside in Dallas or surrounding areasRole Overview:For more than 140 years GSK has pioneered novel research methods and technologies to help protect people from infectious diseases. Our vaccines portfolio of
Territory: Covers Dallas Mesquite Tyler and Longview TXIdeal candidate should reside in Dallas or surrounding areasRole Overview:For more than 140 years GSK has pioneered novel research methods and technologies to help protect people from infectious diseases. Our vaccines portfolio of
Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol
Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol
Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol
Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol
Territory: Covers Dallas Irving Ennis and Southlake TXIdeal candidate should reside in Dallas or surrounding areasRole Overview:For more than 140 years GSK has pioneered novel research methods and technologies to help protect people from infectious diseases. Our vaccines portfolio of
Territory: Covers Dallas Irving Ennis and Southlake TXIdeal candidate should reside in Dallas or surrounding areasRole Overview:For more than 140 years GSK has pioneered novel research methods and technologies to help protect people from infectious diseases. Our vaccines portfolio of
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
MUST BE BASED IN THE UK TO BE ELIGIBLE.Job title: RCI & CAPA Senior ManagerLocation:GSK HQ LondonContract Type: Inside IR35OverviewGSK is a science-led global healthcare company with a special purpose: to help people do more feel better live longer. We are on an audacious journey to i
MUST BE BASED IN THE UK TO BE ELIGIBLE.Job title: RCI & CAPA Senior ManagerLocation:GSK HQ LondonContract Type: Inside IR35OverviewGSK is a science-led global healthcare company with a special purpose: to help people do more feel better live longer. We are on an audacious journey to i
Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol
Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol
Territory: Covers the entire state of Washington and AlaskaThe ideal candidate will reside within WashingtonBusiness Introduction:GSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing s
Territory: Covers the entire state of Washington and AlaskaThe ideal candidate will reside within WashingtonBusiness Introduction:GSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing s
